INITIAL PROSTATE BIOPSY: PCA3 OUTPERFORMS ESTABLISHED RISK FACTORS OF PROSTATE CANCER AND INCREASES MULTIVARIATE PREDICTIVE ACCURACY

被引：0
|
作者：
Auprich, Marco
Haese, Alexander
de la Taille, Alexandre
Graefen, Markus
Kil, Paul
Gontero, Paolo
van Poppel, Hendrik
Stenzl, Arnulf
de Reijke, Theo
Marberger, Michael
Chun, Felix
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.2258
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2156
引用
收藏
页码：E838 / E838
页数：1
相关论文
共 50 条
  • [1] INITIAL PROSTATE BIOPSY: PCA3 OUTPERFORMS ESTABLISHED RISK FACTORS OF PROSTATE CANCER AND INCREASES MULTIVARIATE PREDICTIVE ACCURACY
    Auprich, M.
    Haese, A.
    Graefen, M.
    De La Taille, A.
    De Reijke, T.
    Kil, P.
    Stenzl, A.
    Van Poppel, H.
    Irani, J.
    Gontero, P.
    Marberger, M.
    Chun, F.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 41 - 42
  • [2] PSA VELOCITY AND PCA3 SCORE AS RISK FACTORS FOR PROSTATE CANCER IN A REPEAT BIOPSY SETTING IMPROVES THE PREDICTIVE ACCURACY IN A MULTIVARIATE MODEL
    Auprich, M.
    Budaeus, L.
    Luger, F.
    Pichler, M.
    Galle, G.
    Mannweiler, S.
    Chun, K. F. H.
    Puerstner, P.
    Pummer, K.
    Augustin, H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 307 - 307
  • [3] Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients
    Goode, Roland R.
    Marshall, Susan J.
    Duff, Michael
    Chevli, Eric
    Chevli, K. Kent
    PROSTATE, 2013, 73 (01): : 48 - 53
  • [4] Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
    Jose Rubio-Briones
    Angel Borque
    Luis M. Esteban
    Juan Casanova
    Antonio Fernandez-Serra
    Luis Rubio
    Irene Casanova-Salas
    Gerardo Sanz
    Jose Domínguez-Escrig
    Argimiro Collado
    Alvaro Gómez-Ferrer
    Inmaculada Iborra
    Miguel Ramírez-Backhaus
    Francisco Martínez
    Ana Calatrava
    Jose A. Lopez-Guerrero
    BMC Cancer, 15
  • [5] Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
    Rubio-Briones, Jose
    Borque, Angel
    Esteban, Luis M.
    Casanova, Juan
    Fernandez-Serra, Antonio
    Rubio, Luis
    Casanova-Salas, Irene
    Sanz, Gerardo
    Dominguez-Escrig, Jose
    Collado, Argimiro
    Gomez-Ferrer, Alvaro
    Iborra, Inmaculada
    Ramirez-Backhaus, Miguel
    Martinez, Francisco
    Calatrava, Ana
    Lopez-Guerrero, Jose A.
    BMC CANCER, 2015, 15
  • [6] PCA3 PERMUTATION INCREASES THE PROSTATE BIOPSY YIELD
    Siegrist, Timothy
    Fracchia, John
    JOURNAL OF UROLOGY, 2011, 185 (04): : E397 - E397
  • [7] USE OF PROSTATE CANCER GENE 3 (PCA3) IN DETECTING PROSTATE CANCER IN INITIAL AND REPEAT PROSTATE BIOPSY PATIENTS
    Goode, Roland
    Marshall, Susan
    Chevli, Eric
    Duff, Michael
    Chevli, K. Kent
    JOURNAL OF UROLOGY, 2011, 185 (04): : E763 - E763
  • [8] CAN PROSTATE CANCER GENE 3 (PCA3) PREDICT INITIAL BIOPSY OUTCOME?
    de la Taille, Alexandre
    Irani, Jacques
    de Reijke, Theo M.
    Haese, Alexander
    JOURNAL OF UROLOGY, 2009, 181 (04): : 655 - 655
  • [9] Urinary PCA3 as a Predictor of Prostate Cancer in a Cohort of 3,073 Men Undergoing Initial Prostate Biopsy
    Chevli, K. Kent
    Duff, Michael
    Walter, Peter
    Yu, Changhong
    Capuder, Brian
    Elshafei, Ahmed
    Malczewski, Stephanie
    Kattan, Michael W.
    Jones, J. Stephen
    JOURNAL OF UROLOGY, 2014, 191 (06): : 1743 - 1748
  • [10] Prostate cancer 3 (PCA3) represents a clinically meaningful predictor of prostate cancer at repeat biopsy
    Haese, Alexander
    Chun, Felix K. H.
    de la Taille, Alexandre
    van Poppel, Hendrik
    Marberger, Michael
    Mulders, Peter F.
    Abbou, Clement-Claude C.
    Stenzl, Amulf
    Huland, Hartwig
    Tinzl, Martina
    Remzi, Mesut
    Feyerabend, Suzan
    Van Gils, Martijn
    Stillebroer, Alexander
    Schalken, Jack A.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 724 - 725
12345